Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level. It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition specifically results in polyuria, increase in thrust and hunger. There is high prevalence of type II diabetes worldwide due to increased obesity, urbanization, poor diet and substandard healthcare conditions. The global market for diabetes is highly lucrative for drug and device manufacturers as treatment majorly demands therapeutic and diagnostic management. Global diabetes management market is growing with high CAGR and expected to continue this trend for the forecast period. The report addresses the key themes such as market segmentation and competitive landscape. This report is investigative towards trends, opportunities and challenges present at current marketplace for diabetes management and it also provides ample information therein. In-depth analysis of market dynamics coupled with upcoming trends would be beneficial to professionals. The report would contain detailed information of key leaders with their business share.
Prime driver for global diabetes management market is increasing incidence of type I and type II diabetes combined with high obese population. Additionally, combination therapy as compared to monotherapy is gaining popularity due to its high efficacious nature. Increase in collaborations and alliances are the better avenues to attain high profitability. However, global diabetes management market suffers from some of the critical restrains namely, counterfeiting of drugs, scarcity of healthcare personnel in some countries such as Russia, cost sensitivity and limited infrastructure for management. Emerging economies offer ample opportunities to big players of this market to expand their business. Also, there is a need of improved, efficacious and safe treatment, which can be fulfilled by innovative R&D.
Global Diabetes Management Market by Device Type
The diabetes management market is segmented by type of devices into monitoring, diagnostic, insulin delivery and other devices. Blood glucose monitoring devices has the largest market share, as critical monitoring of glucose level is necessary for the management of diabetes. Also, the insulin delivery devices have increased its sale to promising value, which has resulted in improvement in insulin delivery technology. In this segment, insulin pens are more popular as they are less painful in usage.
Global Diabetes Management Market by Therapeutics
The global diabetes management market is segmented by therapeutics into two broad categories, namely injectables and orally administered drugs. Therapeutic segment as a whole is largely dominated by human insulin and its analogues. Currently, dipeptidyl inhibitors has boosted the market growth and generated high revenue due to its safe nature and once daily dose regimen. Strong R&D pipeline has lead to development of safe and efficacious drugs, which has further fueled the market growth.
Global Diabetes Management Market by Geography
Geographically, diabetes management market is segmented into North America, Europe, Asia and LAMEA. North America and Asia-pacific dominates diabetes management market due to high incidences of diabetes and large pool of aging population. Currently, China is evolving as one of the major pharma market for diabetes care and management. The reasons studied are robust economic growth, ageing population and sweeping healthcare reforms.
Competitive Landscape
The leading companies in global diabetes management market include Abbott Laboratories, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi, Dexcom, Medtronic and Novo Nordisk A/S. Currently, Abbott, Dexcom and Medtronic dominate continuous glucose monitoring devices market and have launched several new products. Eli Lilly and Novo Nordisk have concentrated on Indian market and have launched easy-to-use insulin versions to snatch high market share. Also, companies are focusing on collaborations and partnerships to gain profitability.
High Level Analysis
The study provides in-depth analysis of market drivers, challenges and trends. Competitive landscape section provides explicit information of the big players ruling the global diabetes management market and their operating strategies. The report covers qualitative analysis of market segments and identifies the prime areas for product targeting. Porter’s five forces tool has been utilized to determine the attractiveness within global diabetes management market. Constant demand for safe and efficacious therapeutics and improved technology is responsible to increase the bargaining power of supplier. Innovative, differentiated and easy to use insulin delivery devices tend to decrease the threat of substitute products. Global diabetes management market has experienced a cross segment participation that resulted in shifting the business of big players to more diversified products. Thus, it tends to increase the threat of substitute products and keeps high intensity of rivalry.
KEY BENEFITS
- This report offers the following benefits in particular:
- Qualitative analysis of market trends, drivers and restraints within global diabetes management market
- Identification of leading companies within global diabetes management market combined with ample information on competitive landscape and leading technologies would give a better understanding of the market players and their strategies
- Insightful analysis of different segments helps to understand and capitalize future opportunities
- Identification of emerging economies such as India and China, and opportunities therein
Diabetes Management Market Report Highlights
| Aspects | Details |
 By DEVICE TYPE |
|
 By THERAPEUTICS |
|
 By GEOGRAPHY |
|
 Key Market Players | Eli Lilly and Company, Medtronic, Becton Dickinson, Insulet Corporation, Sanofi, Johnson & Johnson, Dexcom, Abbott Laboratories, Novo Nordisk, Roche Diagnostics |
Loading Table Of Content...
